US 12,006,304 B2
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs
Ulrich Bothe, Berlin (DE); Holger Siebeneicher, Berlin (DE); Nicole Schmidt, San Francisco, CA (US); Reinhard Nubbemeyer, Berlin (DE); Ulf Bömer, Glienicke (DE); Judith Günther, Berlin (DE); Holger Steuber, Berlin (DE); Martin Lange, Berlin (DE); Christian Stegmann, Berlin (DE); Andreas Sutter, Berlin (DE); Alexandra Rausch, Berlin (DE); Christian Friedrich, Brandenburg (DE); and Peter Hauff, Berlin (DE)
Assigned to BAYER PHARMA AKTIENGESELLSCHAFT, Berlin (DE)
Filed by Bayer Pharma Aktiengesellschaft, Berlin (DE)
Filed on Jul. 20, 2022, as Appl. No. 17/869,674.
Application 17/869,674 is a continuation of application No. 17/009,553, filed on Sep. 1, 2020, abandoned.
Application 17/009,553 is a continuation of application No. 16/377,025, filed on Apr. 5, 2019, granted, now 10,793,545, issued on Oct. 6, 2020.
Application 16/377,025 is a continuation of application No. 15/529,996, granted, now 10,308,634, issued on Jun. 4, 2019, previously published as PCT/EP2015/077596, filed on Nov. 25, 2015.
Claims priority of application No. 14195032 (EP), filed on Nov. 26, 2014.
Prior Publication US 2022/0388982 A1, Dec. 8, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 401/12 (2006.01); A61K 31/4439 (2006.01); A61P 19/02 (2006.01); C07D 405/14 (2006.01); C07F 7/18 (2006.01)
CPC C07D 401/12 (2013.01) [A61K 31/4439 (2013.01); A61P 19/02 (2018.01); C07D 405/14 (2013.01); C07F 7/1804 (2013.01)] 9 Claims
 
1. A method for treatment and/or prophylaxis of allergic dermatitis in a non-human animal comprising administering to the non-human animal an effective amount of compound having the structure:

OG Complex Work Unit Chemistry
or a metabolite, a salt, a solvate, a solvate of the salt thereof.